Cargando…
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein
Normal host cells are protected from the destructive action of complement by cell surface complement regulatory proteins. In humans, decay-accelerating factor (DAF) and membrane cofactor protein (MCP) play such a biologic role by inhibiting C3 and C5 convertases. DAF and MCP accomplish this task by...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191854/ https://www.ncbi.nlm.nih.gov/pubmed/7528766 |
Ejemplares similares
-
Expression of Membrane Complement Regulatory Proteins Crry and CD55 in Normal Rats
por: Kato, Chie, et al.
Publicado: (2013) -
Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis
por: Soltys, Jindrich, et al.
Publicado: (2012) -
Structures of the rat complement regulator CrrY
por: Roversi, Pietro, et al.
Publicado: (2011) -
Induction of decay accelerating factor and membrane cofactor protein by resveratrol attenuates complement deposition in human coronary artery endothelial cells
por: Detsika, Maria G., et al.
Publicado: (2019) -
Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth
por: Banadakoppa, Manu, et al.
Publicado: (2020)